臨床泌尿器科73巻12号

2019年11月発行

綜説

限局性前立腺癌に対する手術と外照射放射線療法の比較

著者： 田口慧¹ 福原浩¹

所属機関： ¹杏林大学医学部泌尿器科学教室

ページ範囲：P.869 - P.877

要旨

　手術と外照射放射線療法は，限局性前立腺癌に対する同等の治療選択肢とみなされている．既報では長期生存は手術が勝る可能性が指摘されているが，両者の比較においては異なる患者背景や副作用プロファイルなどの諸問題があり，単純な成績比較は困難である．また，各治療でロボット手術やIMRTといった技術革新も進んでいるため，治療成績をアップデートしていくことも重要である．最近，手術と外照射放射線療法を比較した初のランダム化比較試験の結果が報告された．また，筆者らは最近，両者の先端技術同士の比較論文を出版した．これらの紹介も含め，限局性前立腺癌に対する両モダリティの比較について腫瘍学的成績を中心に概説する．

参考文献

1） Mottet N, Bellmunt J, Bolla M, et al : EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1 : Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 71 : 618-629, 2017

2） Sanda MG, Cadeddu JA, Kirkby E, et al : Clinically Localized Prostate Cancer : AUA/ASTRO/SUO Guideline. Part I : Risk Stratification, Shared Decision Making, and Care Options. J Urol 199 : 683-690, 2018

3） Kakehi Y, Sugimoto M, Taoka R, et al : Evidenced-based clinical practice guideline for prostate cancer （summary : Japanese Urological Association, 2016 edition）. Int J Urol 24 : 648-666, 2017

4） Albertsen PC, Hanley JA, Penson DF, et al : 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort. J Urol 177 : 932-936, 2007

5） Merglen A, Schmidlin F, Fioretta G, et al : Short- and long-term mortality with localized prostate cancer. Arch Intern Med 167 : 1944-1950, 2007

6） Tewari A, Divine G, Chang P, et al : Long-term survival in men with high grade prostate cancer : a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach. J Urol 177 : 911-915, 2007

7） Jeldres C, Suardi N, Walz J, et al : Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer : a population-based study of 6183 men. Eur Urol 54 : 107-116, 2008

8） Nguyen PL, Chen MH, Catalona WJ, et al : Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors. Int J Radiat Oncol Biol Phys 73 : 659-664, 2009

9） Cooperberg MR, Vickers AJ, Broering JM, et al : Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer 116 : 5226-5234, 2010

10） Ladjevardi S, Sandblom G, Berglund A, et al : Tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer. Eur Urol 57 : 631-638, 2010

11） Zelefsky MJ, Eastham JA, Cronin AM, et al : Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer : a comparison of clinical cohorts adjusted for case mix. J Clin Oncol 28 : 1508-1513, 2010

12） Boorjian SA, Karnes RJ, Viterbo R, et al : Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer 117 : 2883-2891, 2011

13） Abdollah F, Schmitges J, Sun M, et al : Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer : a population-based analysis. Int J Urol 19 : 836-844, 2012

14） Kibel AS, Ciezki JP, Klein EA, et al : Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol 187 : 1259-1265, 2012

15） Westover K, Chen MH, Moul J, et al : Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer. BJU Int 110 : 1116-1121, 2012

16） Degroot JM, Brundage MD, Lam M, et al : Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy. Can Urol Assoc J 7 : E299-E305, 2013

17） Hoffman RM, Koyama T, Fan KH, et al : Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. J Natl Cancer Inst 105 : 711-718, 2013

18） Merino T, San Francisco IF, Rojas PA, et al : Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer : long-term follow-up. BMC Cancer 13 : 530, 2013

19） Rice KR, Colombo ML, Wingate J, et al : Low risk prostate cancer in men ≥ 70 years old : to treat or not to treat. Urol Oncol 31 : 755-760, 2013

20） Lee JY, Cho KS, Kwon JK, et al : A competing risk analysis of cancer-specific mortality of initial treatment with radical prostatectomy versus radiation therapy in clinically localized high-risk prostate cancer. Ann Surg Oncol 21 : 4026-4033, 2014

21） Sooriakumaran P, Nyberg T, Akre O, et al : Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer : observational study of mortality outcomes. BMJ 348 : g1502, 2014

22） Sun M, Sammon JD, Becker A, et al : Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer : a comparative effectiveness evaluation. BJU Int 113 : 200-208, 2014

23） Yamamoto S, Kawakami S, Yonese J, et al : Long-term oncological outcome in men with T3 prostate cancer : radical prostatectomy versus external-beam radiation therapy at a single institution. Int J Clin Oncol 19 : 1085-1091, 2014

24） Kim YJ, Cho KH, Pyo HR, et al : Radical prostatectomy versus external beam radiotherapy for localized prostate cancer : Comparison of treatment outcomes. Strahlenther Onkol 191 : 321-329, 2015

25） Taguchi S, Fukuhara H, Shiraishi K, et al : Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer : Comparison of Patient Outcomes Including Mortality. PLoS One 10 : e0141123, 2015

26） Hamdy FC, Donovan JL, Lane JA, et al : ProtecT Study Group. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N Engl J Med 375 : 1415-1424, 2016

27） Wallis CJD, Saskin R, Choo R, et al : Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer : A Systematic Review and Meta-analysis. Eur Urol 70 : 21-30, 2016

28） Kishan AU, Shaikh T, Wang PC, et al : Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy : A Multi-institutional Comparative Analysis. Eur Urol 71 : 766-773, 2017

29） Kishan AU, Cook RR, Ciezki JP, et al : Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. JAMA 319 : 896-905, 2018

30） Taguchi S, Shiraishi K, Fujimura T, et al : Robot-assisted radical prostatectomy versus volumetric modulated arc therapy : comparison of front-line therapies for localized prostate cancer. Radiother Oncol 140 : 62-67, 2019 ［Epub ahead of print］

31） Bill-Axelson A, Holmberg L, Garmo H, et al : Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up. N Engl J Med 379 : 2319-2329, 2018

32） Wilt TJ, Brawer MK, Jones KM, et al : Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367 : 203-213, 2012

33） D'Amico AV, Whittington R, Malkowicz SB, et al : Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 : 969-974, 1998

34） Kupelian PA, Potters L, Khuntia D, et al : Radical prostatectomy, external beam radiotherapy < 72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58 : 25-33, 2004

35） Aizer AA, Yu JB, Colberg JW, et al : Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol 93 : 185-191, 2009

36） Roach M 3rd : Radical prostatectomy v radiation : only a randomised trial can provide the answer. BMJ 348 : g2266, 2014

37） Mir MC, Li J, Klink JC, et al : Optimal definition of biochemical recurrence after radical prostatectomy depends on pathologic risk factors : identifying candidates for early salvage therapy. Eur Urol 66 : 204-210, 2014

38） Roach M 3rd, Hanks G, Thames H Jr, et al : Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer : recommendations of the RTOG-ASTRO phoenix consensus conference. Int J Radiat Oncol Biol Phys 65 : 965-974, 2006

39） Morris WJ, Pickles T and Keyes M : Using a surgical prostate-specific antigen threshold of > 0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial. Brachytherapy 17 : 837-844, 2018

40） Charlson ME, Pompei P, Ales KL, et al : A new method of classifying prognostic comorbidity in longitudinal studies : development and validation. J Chronic Dis 40 : 373-383, 1987

41） Wolff D, Stieler F, Welzel G, et al : Volumetric modulated arc therapy （VMAT） vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 93 : 226-233, 2009

42） D'Amico AV, Whittington R, Malkowicz SB, et al : Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 : 969-974, 1998

43） 厚生労働省 : 平成30年簡易生命表.　https://www.mhlw.go.jp/toukei/saikin/hw/life/life18/index.html （2019年8月21日閲覧）

44） Aminsharifi A and Polascik TJ : Re : Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost and Disease Progression and Mortality in Patients with Gleason Score 9-10 Prostate Cancer. Eur Urol 74 : 526, 2018